I dette forsøg havde 87% af patienterne sygdom, som var IHC3+ og 95% af patienterne havde sygdom, der var IHC3+ og/ eller FISH- positiv.
In this trial, 87% of patients entered had disease that was IHC3+, and 95% of patients entered had disease that was IHC3+ and/ or FISH-positive.